Trident Texofab (BOM:540726) ROCE %: -10.65% (As of Mar. 2026)


BOM:540726 Trident Texofab Ltd BOM:540726
64 GF Score
Price ₹31.95
GF Value ₹63.39
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Trident Texofab ROCE %?

Trident Texofab BOM:540726 -2.17% 64 ROCE % is -10.65% as of Mar. 2026. GuruFocus rates BOM:540726 with a GF Score™ of 64/100 and a GF Value™ of ₹63.39 (Possible Value Trap). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Trident Texofab's annualized ROCE % for the quarter that ended in Mar. 2026 was -10.65%.

Trident Texofab  (BOM:540726) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Trident Texofab ROCE % Related Terms

Trident Texofab ROCE % Historical Data

* Premium members only.

The historical data trend for Trident Texofab's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trident Texofab ROCE % Chart

Trident Texofab Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.47 20.51 17.31 14.33 6.29

Trident Texofab Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.15 14.00 13.75 8.98 -10.65
BOM:540726
64GF Score
Trident Texofab Ltd BOM:540726
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trident Texofab ROCE % Calculation

Trident Texofab's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=42.1/( ( (1005.756 - 407.499) + (1111.568 - 372.05) )/ 2 )
=42.1/( (598.257+739.518)/ 2 )
=42.1/668.8875
=6.29 %

Trident Texofab's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-78.744/( ( (0 - 0) + (1111.568 - 372.05) )/ 1 )
=-78.744/( ( 0 + 739.518 )/ 1 )
=-78.744/739.518
=-10.65 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -10.65% mean?
Trident Texofab (BOM:540726) has a ROCE % of -10.65% as of Mar. 2026.
Is Trident Texofab's ROCE % too high?
Trident Texofab's current ROCE % is -10.65%. Overall, Trident Texofab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Texofab's ROCE % compare to competitors?
Trident Texofab's ROCE % of -10.65% can be compared against companies in the Manufacturing - Apparel & Accessories industry. The industry median ROCE % is 6.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Manufacturing - Apparel & Accessories company?
The median ROCE % among Manufacturing - Apparel & Accessories companies is 6.11, based on 1,033 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Manufacturing - Apparel & Accessories industry, the median ROCE % is 6.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trident Texofab's current ROCE % is -10.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Texofab stock overvalued right now?
Based on GuruFocus' analysis, Trident Texofab (BOM:540726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.39, compared to a current price of ₹31.95 — trading 49.6% below its estimated fair value. The current ROCE % is -10.65%. Trident Texofab's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Trident Texofab (BOM:540726), the current ROCE % is -10.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trident Texofab (BOM:540726) Overvalued in 2026?

Based on GuruFocus' analysis, Trident Texofab stock appears to be undervalued. The current stock price of ₹31.95 is trading 49.6% below its estimated GF Value™ of ₹63.39. GuruFocus considers Trident Texofab to be Possible Value Trap.

Key valuation signals for BOM:540726:

  • ROCE %: -10.65%
  • GF Value™: ₹63.39 vs. price of ₹31.95 (49.6% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the BOM:540726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trident Texofab Business Description

Address Ring Road, Nodh-4/1650, Sahara Darwaja, 2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Surat, GJ, IND, 395003
Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. Its brands are Storia Of Shed, Light Trail, Comfy Zoi, and Alicon. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.
64GF Score

Get the complete analysis for BOM:540726

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹31.95
Price
₹63.39
GF Value